Desjardins, A., Sampson, J. H., Peters, K. B., Ranjan, T., Vlahovic, G., Watts, J., … Gromeier, M. (2014). Phase I study of the intratumoral administration of an oncolytic polio/rhinovirus recombinant (PVSRIPO) in recurrent glioblastoma (GBM). In Journal of Clinical Oncology (Vol. 32, pp. TPS2106–TPS2106). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.tps2106

Desjardins, Annick, John Howard Sampson, Katherine B. Peters, Tulika Ranjan, Gordana Vlahovic, Jason Watts, Stevie Threatt, et al. “Phase I study of the intratumoral administration of an oncolytic polio/rhinovirus recombinant (PVSRIPO) in recurrent glioblastoma (GBM).” In Journal of Clinical Oncology, 32:TPS2106–TPS2106. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.tps2106.

Desjardins A, Sampson JH, Peters KB, Ranjan T, Vlahovic G, Watts J, et al. Phase I study of the intratumoral administration of an oncolytic polio/rhinovirus recombinant (PVSRIPO) in recurrent glioblastoma (GBM). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. TPS2106–TPS2106.

Desjardins, Annick, et al. “Phase I study of the intratumoral administration of an oncolytic polio/rhinovirus recombinant (PVSRIPO) in recurrent glioblastoma (GBM).” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. TPS2106–TPS2106. Crossref, doi:10.1200/jco.2014.32.15_suppl.tps2106.

Desjardins A, Sampson JH, Peters KB, Ranjan T, Vlahovic G, Watts J, Threatt S, Herndon JE, Boulton S, Lally-Goss D, McSherry F, Friedman AH, Friedman HS, Bigner DD, Gromeier M. Phase I study of the intratumoral administration of an oncolytic polio/rhinovirus recombinant (PVSRIPO) in recurrent glioblastoma (GBM). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. TPS2106–TPS2106.